A Distinct Translation Initiation Mechanism Generates Cryptic Peptides for Immune Surveillance

MHC class I molecules present a comprehensive mixture of peptides on the cell surface for immune surveillance. The peptides represent the intracellular protein milieu produced by translation of endogenous mRNAs. Unexpectedly, the peptides are encoded not only in conventional AUG initiated translational reading frames but also in alternative cryptic reading frames. Here, we analyzed how ribosomes recognize and use cryptic initiation codons in the mRNA. We find that translation initiation complexes assemble at non-AUG codons but differ from canonical AUG initiation in response to specific inhibitors acting within the peptidyl transferase and decoding centers of the ribosome. Thus, cryptic translation at non-AUG start codons can utilize a distinct initiation mechanism which could be differentially regulated to provide peptides for immune surveillance.

[1]  Pamela A. Silver,et al.  Functional Specificity among Ribosomal Proteins Regulates Gene Expression , 2007, Cell.

[2]  P. Jensen.  Recent advances in antigen processing and presentation , 2007, Nature Immunology.

[3]  N. Shastri,et al.  The final touches make perfect the peptide-MHC class I repertoire. , 2007, Immunity.

[4]  M. Palkovits,et al.  Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N‐terminal leucine , 2007, The FEBS journal.

[5]  Jennifer A. Doudna,et al.  5 Translation Initiation by Viral Internal Ribosome Entry Sites , 2007 .

[6]  W. Green,et al.  Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected , 2006, The Journal of Immunology.

[7]  J. Yewdell,et al.  The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.

[8]  Wei Xu,et al.  Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita , 2006, Science.

[9]  C. Hellen,et al.  Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex. , 2006, Genes & development.

[10]  Peter Cresswell,et al.  Mechanisms of MHC class I‐restricted antigen processing and cross‐presentation , 2005, Immunological reviews.

[11]  N. Shastri,et al.  All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen‐processing pathway , 2005, Immunological reviews.

[12]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[13]  N. Shastri,et al.  Unanticipated Antigens: Translation Initiation at CUG with Leucine , 2004, PLoS biology.

[14]  J. Pelletier,et al.  Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. , 2004, Nucleic acids research.

[15]  Daniel N. Wilson,et al.  Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding. , 2004, Molecular cell.

[16]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[17]  N. Shastri,et al.  Constitutive Display of Cryptic Translation Products by MHC Class I Molecules , 2003, Science.

[18]  P. Sarnow.  Viral Internal Ribosome Entry Site Elements: Novel Ribosome-RNA Complexes and Roles in Viral Pathogenesis , 2003, Journal of Virology.

[19]  C. Hellen,et al.  Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. , 2003, Genes & development.

[20]  G. Edelman,et al.  The ribosome filter hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Goldberg,et al.  Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.

[22]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.

[23]  M. Buchmeier,et al.  Cutting Edge: Neosynthesis Is Required for the Presentation of a T Cell Epitope from a Long-Lived Viral Protein1 , 2001, The Journal of Immunology.

[24]  A Yonath,et al.  Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3 , 2001, The EMBO journal.

[25]  N. Brouwenstijn,et al.  Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens. , 2000, Immunity.

[26]  P. Sarnow,et al.  Initiation of Protein Synthesis from the A Site of the Ribosome , 2000, Cell.

[27]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[28]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[29]  N. Nakashima,et al.  Methionine-independent initiation of translation in the capsid protein of an insect RNA virus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Hershey,et al.  2 The Pathway and Mechanism of Initiation of Protein Synthesis , 2000 .

[31]  J. Nyborg,et al.  3 The Protein Biosynthesis, Elongation Cycle , 2000 .

[32]  N. Shastri,et al.  Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. , 1999, Immunity.

[33]  M. Chun,et al.  Methionyl adenylate analogues as inhibitors of methionyl-tRNA synthetase. , 1999, Bioorganic & medicinal chemistry letters.

[34]  M. Kozak.  Primer extension analysis of eukaryotic ribosome-mRNA complexes. , 1998, Nucleic acids research.

[35]  M. Brostrom,et al.  Regulation of translational initiation during cellular responses to stress. , 1998, Progress in nucleic acid research and molecular biology.

[36]  R. Garrett,et al.  Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. , 1995, Journal of molecular biology.

[37]  U. RajBhandary,et al.  Initiator tRNAs and Initiation of Protein Synthesis , 1995 .

[38]  N. Shastri,et al.  LacZ inducible, antigen/MHC-specific T cell hybrids. , 1994, International immunology.

[39]  W. Merrick,et al.  Analysis of 40 S and 80 S complexes with mRNA as measured by sucrose density gradients and primer extension inhibition. , 1992, The Journal of biological chemistry.

[40]  D. Peabody,et al.  Translation initiation at non-AUG triplets in mammalian cells. , 1989, The Journal of biological chemistry.

[41]  A. Cigan,et al.  tRNAi(met) functions in directing the scanning ribosome to the start site of translation. , 1988, Science.

[42]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[43]  M. Kozak,et al.  Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo , 1984, Nature.

[44]  C. Danzin,et al.  Synthesis and biochemical properties of chemically stable product analogues of the reaction catalyzed by S-adenosyl-L-methionine decarboxylase. , 1982, Journal of medicinal chemistry.

[45]  A. Shatkin,et al.  Migration of 40 S ribosomal subunits on messenger RNA in the presence of edeine. , 1978, The Journal of biological chemistry.

[46]  S. Horwitz,et al.  Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. , 1976, Molecular pharmacology.

[47]  S. M. Kupchan,et al.  The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica. , 1975, The Journal of organic chemistry.